Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

CONSHOHOCKEN, Pa., February 07, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...

Cencora has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale ...

Cencora has a 12-month low of $214.77 and a 12-month high of $262.26. The company has a market capitalization of $47.71 billion, a PE ratio of 35.11, a price-to-earnings-growth ratio of 1.49 and a ...

Cencora, Inc. (NYSE:COR – Free Report) – Equities researchers at Leerink Partnrs lifted their Q3 2025 earnings estimates for Cencora in a research report issued on Wednesday, February 5th.

Cencora COR underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on ...

CONSHOHOCKEN, Pa., February 07, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC ...